IRIS
CIGLIANO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.988
EU - Europa 864
AS - Asia 386
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 7
SA - Sud America 3
Totale 3.262
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.975
UA - Ucraina 404
CN - Cina 326
DE - Germania 145
IT - Italia 130
SE - Svezia 60
FI - Finlandia 56
FR - Francia 19
GB - Regno Unito 18
BE - Belgio 16
ID - Indonesia 16
KR - Corea 14
CA - Canada 12
AU - Australia 7
DZ - Algeria 7
TR - Turchia 7
EU - Europa 6
IN - India 5
IR - Iran 4
NL - Olanda 4
RO - Romania 4
SG - Singapore 4
BR - Brasile 3
AL - Albania 2
JP - Giappone 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BY - Bielorussia 1
DK - Danimarca 1
HK - Hong Kong 1
IQ - Iraq 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MX - Messico 1
PL - Polonia 1
RU - Federazione Russa 1
Totale 3.262
Salva come PNG Salva come JPEG
Città #
Chandler 645
Jacksonville 225
Princeton 184
Nanjing 102
Sassari 88
Ann Arbor 79
New York 73
Wilmington 64
Beijing 41
Dearborn 41
Nanchang 35
Boardman 32
Mountain View 25
Ashburn 22
Shenyang 22
Woodbridge 22
Changsha 19
Brussels 16
Hebei 15
Andover 14
Jiaxing 14
Seoul 14
Norwalk 13
San Francisco 13
Tianjin 12
Zhengzhou 11
Helsinki 10
Houston 10
Jinan 10
Kunming 10
Ningbo 10
Toronto 9
Fairfield 8
Falls Church 8
Algiers 7
Guangzhou 5
Hangzhou 5
Izmir 5
Melbourne 5
Cagliari 4
Monmouth Junction 4
Seattle 4
Singapore 4
Augusta 3
Ficarazzi 3
Los Angeles 3
Ardabil 2
Auburn Hills 2
Beinasco 2
Cambridge 2
Como 2
Haikou 2
Hanover 2
Hefei 2
IJsselstein 2
Lanzhou 2
Messina 2
Paris 2
Riyadh 2
Somerville 2
St Louis 2
Taizhou 2
West Jordan 2
Agropoli 1
Alghero 1
Almere Stad 1
Baghdad 1
Buffalo 1
Carbonia 1
Central 1
Clearwater 1
Colombo 1
Delhi 1
Easton 1
Edmonton 1
Fazenda Rio Grande 1
Frankfurt am Main 1
Fremont 1
Fuzhou 1
Heidelberg 1
Jinhua 1
Kemerovo 1
Latham 1
Leawood 1
London 1
Luxembourg 1
Manchester 1
Markham 1
Markranstaedt 1
Marrùbiu 1
Media 1
Mexico City 1
Minsk 1
Motru 1
Mumbai 1
Osaka 1
Ottawa 1
Pistoia 1
Qingdao 1
Redwood City 1
Totale 2.039
Salva come PNG Salva come JPEG
Nome #
Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma 89
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans 69
A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. IF 2009: 4.522 JCR: Q1 64
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 64
4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras protooncogenes 61
Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans 61
MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes 59
Loss of Fbxw7 synergizes with activated AKT signaling to promote c-Myc dependent cholangiocarcinogenesis 57
Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans 56
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 56
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells 54
Activation of β-Catenin and Yap1 in Human Hepatoblastoma and Induction of Hepatocarcinogenesis in Mice. 53
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis 52
The mTORC2-Akt1 Cascade Is Crucial for c-Myc to Promote Hepatocarcinogenesis in Mice and Humans 52
Differential distribution of structural components and hydration in aortic and pulmonary heart valve conduits: Impact of detergent-based cell removal. IF 2010: 4.824 JCR: Q1 52
Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma 50
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 50
Association between human plasma chondroitin sulphate isomers and carotid atherosclerotic plaque 49
Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice 49
Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways. 48
Combined CDK4/6 and pan-mTOR inhibition is synergistic against intrahepatic cholangiocarcinoma 47
The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models 46
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 46
Apolipoprotein profiles in atherosclerotic disease 45
SKP2 cooperates with N-Ras or AKT to induce liver tumor development in mice 45
Apolipoprotein Profiles in Atherosclerotic Disease 44
Molecular and metabolic changes in human liver clear cell foci resemble the alterations occurring in rat hepatocarcinogenesis. 44
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice 44
Functional crosstalk between AKT/mTOR and Ras/MAPK pathways in hepatocarcinogenesis: implications for the treatment of human liver cancer. 44
Apolipoprotein Profiles in Atherosclerotic Disease 44
SNAI1 promotes the cholangiocellular phenotype, but not epithelial-mesenchymal transition, in a murine hepatocellular carcinoma model 43
TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma 42
Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver 42
Ultrasensitive Capillary Zone Electrophoresis (CZE) for glycosaminoglycan analisys in normal human plasma 42
Structural analisys of plasma glycosaminoglycans in patients with atheromatous lesions 41
PI3K/AKT/mTOR pathway plays a major pathogenetic role in glycogen accumulation and tumor development in renal distal tubules of rats and men. 41
Human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 40
Glycosaminoglycan content and distribution in human normal and varicose veins 39
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 39
Apolipoprotein profiles in atherosclerotic disease 39
Loss of pten synergizes with c-met to promote hepatocellular carcinoma development via mTORC2 pathway 39
Modification of the base excision repair enzyme MBD4 by the small ubiquitin-like molecule SUMO1 38
Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans 38
Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma 37
Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis 37
PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells 37
New Capillary Zone Electrophoresis (CZE) method for glycosaminoglycan analysis 37
Proteomic study of differential protein expression in stable and unstable human atherosclerotic plaque 36
Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model 36
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice 36
Human serum albumin Cys34 oxidative modifications after infiltration in the carotid atherosclerotic plaque 35
Pivotal role of fatty acid synthase in c-myc driven hepatocarcinogenesis 35
GLYCOSAMINOGLYCAN DIVERSITY IN MARINE SPONGE EXTRACELLULAR MATRIX 32
Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles 32
Oncogene-dependent addiction to carbohydrate-responsive element binding protein in hepatocellular carcinoma 32
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 32
Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans 32
Transcriptomic and Proteomic Analysis of Clear Cell Foci (CCF) in the Human Non-Cirrhotic Liver Identifies Several Differentially Expressed Genes and Proteins with Functions in Cancer Cell Biology and Glycogen Metabolism 31
The Hippo Effector Transcriptional Coactivator with PDZ-Binding Motif Cooperates with Oncogenic β-Catenin to Induce Hepatoblastoma Development in Mice and Humans 31
Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma 30
Glycosaminoglycans and fabry’s disease 30
Fine structure of glycosaminoglycans from fresh and decellularized porcine cardiac valves and pericardium 30
Role of the Notch signaling in cholangiocarcinoma 30
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 29
Structural analysis of plasma glycosaminoglycans in patients undergoing carotid endarterectomy 28
Proteomic study of differential protein expression in stable and unstable human atherosclerotic plaque 28
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 27
Structural analysis of glycosaminoglycans from fresh porcine aortic valves 26
Erratum: Frizzled-10 extracellular vesicles plasma concentration is associated with tumoral progression in patients with colorectal and gastric cancer (Journal of Oncology (2019) 2019 (2715968) DOI: 10.1155/2019/2715968) 26
Nuclear localization dictates hepatocarcinogenesis suppression by glycine N-methyltransferase 25
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 25
Oncogenic potential of N-terminal deletion and S45Y mutant β-catenin in promoting hepatocellular carcinoma development in mice 24
Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis. 24
Aortic and pulmonary bioprosthetic heart valves: an insight on glycosaminoglycan distribution and fine structure in decellularized porcine scaffolds for tissue engineering purposes 24
Functional role of SGK3 in PI3K/Pten driven liver tumor development 22
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease 21
MEK inhibition suppresses K-Ras wild-type cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironment 20
Overexpression of SMAD7 activates the YAP/NOTCH cascade and promotes liver carcinogenesis in mice and humans 19
Glycosaminoglycan diversity in marine sponge extracellular matrix 19
CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype 19
Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade 19
Focal adhesion kinase activation limits efficacy of Dasatinib in c-Myc driven hepatocellular carcinoma 19
Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development 19
Current challenges to underpinning the genetic basis for cholangiocarcinoma 18
Corrigendum to ‘TAZ is indispensable for c-MYC-induced hepatocarcinogenesis’ [J Hepatol (2022) 123–134] (Journal of Hepatology (2022) 76(1) (123–134), (S016882782102016X), (10.1016/j.jhep.2021.08.021)) 16
Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair 16
Frizzled-10 Extracellular Vesicles Plasma Concentration Is Associated with Tumoral Progression in Patients with Colorectal and Gastric Cancer 12
Signaling and molecular networks related to development and inflammation involved in CCA initiation and progression 8
eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma 7
TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives 5
RASSF1A independence and early galectin-1 upregulation in PIK3CA-induced hepatocarcinogenesis: new therapeutic venues 5
Hepatocellular glycogenotic foci after combined intraportal pancreatic islet transplantation and knockout of the carbohydrate responsive element binding protein in diabetic mice 5
Quantification of liver proton-density fat fraction in 7.1T preclinical MR systems: Impact of the fitting technique 5
TAZ is indispensable for c-MYC-induced hepatocarcinogenesis 4
Molecular and metabolic changes in human clear cell liver foci 4
Totale 3.353
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.010
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.010
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201964 0 0 0 0 0 0 0 0 0 0 4 60
2019/2020596 169 3 47 7 60 39 88 9 74 18 82 0
2020/2021586 61 4 118 5 67 29 84 4 91 83 33 7
2021/2022479 37 3 2 4 13 10 21 28 45 24 81 211
2022/20231.114 116 115 48 178 106 167 0 113 189 7 40 35
2023/2024243 52 18 5 13 83 37 2 14 0 5 14 0
Totale 3.353